It is great to see you here. To see all contents of the website, please register or restore your access.
We believe you will come back gladly.
As of 27 May 2022, the company's activities are fully compliant with Regulation (EU) 2017/746 of the European Parliament and of the Council, as amended. We could continue to offer and sell the whole portfolio of more than 80 CE IVD products under the new EU IVD rules. See more details.
The Quality Management System of GeneProof a.s. is certified according to ČSN EN ISO 13485 ed. 2:2016. The subject of certification is the design, development, manufacturing, and sales of in vitro diagnostic medical devices.
We have also successfully completed a quality management system audit in accordance with Regulation (EU) 2017/746 of the European Parliament and of the Council. This audit confirms that the GeneProof management system is fully aligned to the standard and is fully operational within the organization. The audit was conducted by the notified body BSI Group The Netherlands B.V. (NB 2797). Based on the audit, the notified body can issue an EU quality management system certificate.
The quality of the manufacturer GeneProof a.s. has been certified as meeting the requirements of Directive 98/79/EC of in vitro diagnostic for the following producs:
The Notified Body No 1023 has declared that GeneProof a.s. has implemented a quality assurance system for the design, manufacture, and final inspection of the respective devices in accordance with IVDD Annex IV. This quality assurance system conforms to the requirements of Directive 98/79/EC and is subjected to periodical surveillance.
The Notified Body No. 1023 has performed an examination of the design dossier relating to devices in accordance with IVDD Annex IV. The design of the devices stated below conforms to the requirements of this Directive.
All GeneProof products are regularly tested in External Quality Assessment Panels of QCMD and Instand e.V. For detailed information see the product page.
We provide full support to our partners in the area of Regulatory affairs in the countries of operation. We closely cooperate with our distributors and prepare the registration documentation based on specific legislative requirements of National Authorities.
GeneProof a.s. sees the new regulation as a really big opportunity.
Our company has already utilized the opportunity of the transitional period and has got the IVDD CE certificates for all GeneProof PCR kits listed in Lists A and B valid until 2024.
GeneProof is completing all necessary documentation and testings for the technical files. We are not expected to reduce the number of CE IVD kits; contrariwise completing its STI and Respiratory lines.
IVDR is the top priority of the GP management and entire staff.
The Company takes care of recycling packaging materials from the purchased base materials and it participates in assuring returning and recycling of packaging waste organized by the EKO-KOM company under the identification number EK-F00041495. Disposal of potentially infectious waste is organized by an external supplier.
GeneProof with ALPCO will start conquering the USA market at the AACC 2022 Clinical Lab Expo! Will you be…
GeneProof is IVDR ready company!